Provided by Tiger Fintech (Singapore) Pte. Ltd.

iTeos Therapeutics

6.85
-0.2200-3.11%
Volume:426.18K
Turnover:2.92M
Market Cap:262.18M
PE:-2.22
High:7.33
Open:7.24
Low:6.58
Close:7.07
Loading ...

iTeos Therapeutics Reports Q1 2025 Financial Results

TIPRANKS
·
6 hours ago

iTeos Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Yesterday

iTeos Therapeutics (ITOS) Receives a Buy from Piper Sandler

TIPRANKS
·
Yesterday

iTeos Therapeutics reports Q1 EPS (80c), consensus (90c)

TIPRANKS
·
Yesterday

Iteos Therapeutics Inc: Cash Balance and Investment Balance of $624.3 Mln as of March 31, 2025 Expected to Provide Runway Through 2027

THOMSON REUTERS
·
Yesterday

iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates

GlobeNewswire
·
Yesterday

Positive week for iTeos Therapeutics, Inc. (NASDAQ:ITOS) institutional investors who lost 38% over the past year

Simply Wall St.
·
19 Apr

iTeos Therapeutics (ITOS) Gets a Buy from Piper Sandler

TIPRANKS
·
31 Mar

iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025

GlobeNewswire
·
26 Mar

iTeos Therapeutics: Poised for Success with Anti-TIGIT Therapies Amidst Competitive Landscape

TIPRANKS
·
07 Mar

iTeos Therapeutics Is Maintained at Overweight by JP Morgan

Dow Jones
·
07 Mar

iTeos Therapeutics price target lowered to $17 from $19 at Wells Fargo

TIPRANKS
·
06 Mar

Promising Developments and Strategic Updates Drive Buy Rating for iTeos Therapeutics

TIPRANKS
·
06 Mar

iTeos Therapeutics: Undervalued with Promising Pipeline and Strong Financial Position

TIPRANKS
·
06 Mar

iTeos Therapeutics Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.
·
06 Mar

BUZZ-iTeos Therapeutics rises after reporting narrower-than-expected quarterly loss

Reuters
·
06 Mar

Iteos Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

Iteos Therapeutics Inc expected to post a loss of $1.06 a share - Earnings Preview

Reuters
·
05 Mar

ITeos Therapeutics Q4 2024 GAAP EPS $(1.01) Beats $(1.06) Estimate, Cash Balance And Investment Balance Of $655M As Of December 31, 2024 Expected To Provide Runway Through 2027

Benzinga
·
05 Mar

Iteos Therapeutics Inc - Cash Balance of $655 Million Expected to Provide Runway Through 2027

THOMSON REUTERS
·
05 Mar